Sub-optimal ACE-inhibitor prescribing and increased all-cause mortality risk. A critical evaluation of routine clinical care.
Hall
A
A
Institute for Cardiovascular Research, University of Leeds, UK.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004363:Drug Utilization / Q000592:standards / Q000706:statistics & numerical data*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000706:statistics & numerical data*; D011446:Prospective Studies; D015996:Survival Rate
D000806:Angiotensin-Converting Enzyme Inhibitors